Tipifarnib and Bortezomib Are Synergistic and Overcome Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma and Acute Myeloid Leukemia
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-1792
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2006
Authors
Publisher
American Association for Cancer Research (AACR)